Please Wait.....
Report
Middle East and Africa Respiratory Inhalers Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Middle East and Africa Respiratory Inhalers Market Report and Forecast 2024-2032
Middle East and Africa Respiratory Inhalers Market Size
The global respiratory inhalers market was valued at USD 33.5 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the rising burden of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is expected to grow at a CAGR of 4.9% during the forecast period of 2024-2032, with the values likely to attain USD 53.9 billion by 2032.
Middle East and Africa Respiratory Inhalers Market Outlook
- Recent data reveals that the prevalence of asthma is relatively high in the United Arab Emirates, affecting 10-15% of the adult population along with 20-25% of school-aged children. Similarly, in South Africa, it causes substantial loss of life.
- One of the major Middle East and Africa respiratory inhalers market trends is the rising investments in the development of eco-friendly inhaler technology. In April 2024 , Mundipharma, in collaboration with Vectura announced plans to reformulate an established flutiform pressurized metered-dose inhaler (pMDI), aiming to reduce the product's carbon footprint by incorporating an environmentally friendly propellant.
- The market share is influenced by the growing preference for combination inhaler therapies which consist of multiple medications in a single inhaler device, thereby driving the demand for combination inhalers.
Middle East and Africa Respiratory Inhalers Market Analysis
Respiratory inhalers are used to administer medication directly into the lungs to treat respiratory conditions. These devices contain different types of medications such as bronchodilators (to relax the muscles in the airways), corticosteroids (to reduce inflammation), and combination therapies (containing both bronchodilators and corticosteroids). There is a growing shift towards the development of combination inhaler therapies which consists of multiple medications in a single inhaler device, driving the demand for combination inhalers (aerosol or dry powder inhalers). Further, the rising advancements in digital inhaler technologies such as smart inhalers are expected to significantly contribute to the Middle East and Africa respiratory inhalers market growth.
The market is influenced by rising burden of respiratory conditions that directly impact the demand for effective respiratory inhalers. Recent data reveals that the prevalence of asthma is relatively high in the United Arab Emirates, accounting for 10-15% of the adult population and 20-25% of school-aged children. Similarly, it is estimated that over 10-15% of adults and 20% of children in South Africa are affected by asthma along with a high number of deaths caused by the condition. This increasing prevalence of respiratory diseases, attributed to factors such as smoking, air pollution, and changing lifestyle patterns, is anticipated to fuel the Middle East and Africa respiratory inhalers market demand in the coming years.
One of the major market trends include an increasing focus on the development of eco-friendly inhaler technologies in the region. For instance, in April 2024 , Mundipharma (a global healthcare company with a strong presence in the Middle East and Africa) in collaboration with contract development and manufacturing organization (CDMO) Vectura announced plans to reformulate an established flutiform pressurized metered-dose inhaler (pMDI) for asthma treatment. The remodelling aims at reducing the product's carbon footprint by incorporating an environment friendly propellant. The growing efforts toward the advancement of respiratory inhaler technology with a lower environmental impact is projected to elevate the market value.
Middle East and Africa Respiratory Inhalers Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Dry Powdered Inhalers
- Metered Dose Inhalers
- Soft Mist Inhalers
- Nebulizers
o Jet Nebulizers
o Ultrasonic Nebulizers
o Mesh Nebulizers
Market Breakup by Type
- Conventional Inhalers
- Smart Inhalers
Market Breakup by Indication
- Asthma
- COPD
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by End Use
- Hospitals
- Clinics
- Homecare Settings
- Others
Market Breakup by Countries
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Leading Players in the Middle East and Africa Respiratory Inhalers Market
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- Pari Respiratory Equipment, Inc.
- Teva Pharmaceutical Industries Ltd
- OPKO Health, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Middle East and Africa respiratory inhalers market forecast outlook for 2024-2032?
The Middle East and Africa respiratory inhalers market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 53.9 billion by 2032.
- What are the major factors aiding the Middle East and Africa respiratory inhalers market demand?
The rising burden of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is fuelling the demand for the market.
- What are the major Middle East and Africa respiratory inhalers market trends?
One of the significant trends in the market is the rising investments in the development of sustainable respiratory inhalers. In April 2024, Mundipharma, in collaboration with Vectura announced plans to reformulate an established flutiform pressurized metered-dose inhaler (pMDI) with the aim to reduce the product's carbon footprint by incorporating an environmentally friendly propellant.
- What is the market segmentation based on the product?
Based on the product, the market is segmented into dry powder inhalers, metered dosed inhalers, soft mist inhalers, and nebulizers. The nebulizer category is further bifurcated into jet nebulizers ultrasonic nebulizers, and mesh nebulizers.
- What is the market breakup by type?
By type, the market is divided into conventional inhalers and smart inhalers.
- What is the market segmentation based on the indication?
The market breakup by indication includes asthma and COPD.
- What are the major end users of respiratory inhalers?
End users of the market are hospitals, clinics, and homecare settings, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.
- Who are the key players involved in the Middle East and Africa respiratory inhalers market?
The key players in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Ltd, GSK Plc, Koninklijke Philips NV, OMRON Corp, Pari Respiratory Equipment, Inc., Teva Pharmaceutical Industries Ltd., and OPKO Health, Inc.
Meta description
The Middle East and Africa respiratory inhalers market is poised for growth, driven by the expansion of the global market, which was valued at USD 33.5 billion in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Middle East and Africa Respiratory Inhalers Market Overview
3.1 Middle East and Africa Respiratory Inhalers Market Historical Value (2017-2023)
3.2 Middle East and Africa Respiratory Inhalers Market Forecast Value (2024-2032)
4 Middle East and Africa Respiratory Inhalers Market Landscape*
4.1 Middle East and Africa Respiratory Inhalers: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Middle East and Africa Respiratory Inhalers: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
5 Middle East and Africa Respiratory Inhalers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Middle East and Africa Respiratory Inhalers Market Segmentation (2017-2032)
6.1 Middle East and Africa Respiratory Inhalers Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Dry Powder Inhalers
6.1.3 Metered Dosed Inhalers
6.1.4 Soft Mist Inhalers
6.1.5 Nebulizers
6.1.5.1 Jet Nebulizers
6.1.5.2 Ultrasonic Nebulizers
6.1.5.3 Mesh Nebulizers
6.2 Middle East and Africa Respiratory Inhalers Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Conventional Inhalers
6.2.3 Smart Inhalers
6.3 Middle East and Africa Respiratory Inhalers Market (2017-2032) by Indication
6.3.1 Market Overview
6.3.2 Asthma
6.3.3 COPD
6.4 Middle East and Africa Respiratory Inhalers Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Middle East and Africa Respiratory Inhalers Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 Saudi Arabia
6.5.3 United Arab Emirates
6.5.4 Nigeria
6.5.5 South Africa
6.5.6 Others
7 Saudi Arabia Respiratory Inhalers Market (2017-2032)
7.1 Saudi Arabia Respiratory Inhalers Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Dry Powder Inhalers
7.1.3 Metered Dosed Inhalers
7.1.4 Soft Mist Inhalers
7.1.5 Nebulizers
7.1.5.1 Jet Nebulizers
7.1.5.2 Ultrasonic Nebulizers
7.1.5.3 Mesh Nebulizers
7.2 Saudi Arabia Respiratory Inhalers Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Conventional Inhalers
7.2.3 Smart Inhalers
7.3 Saudi Arabia Respiratory Inhalers Market (2017-2032) by Indication
7.3.1 Market Overview
7.3.2 Asthma
7.3.3 COPD
7.4 Saudi Arabia Respiratory Inhalers Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Clinics
7.4.4 Homecare Settings
7.4.5 Others
8 United Arab Emirates Respiratory Inhalers Market (2017-2032)
8.1 United Arab Emirates Respiratory Inhalers Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Dry Powder Inhalers
8.1.3 Metered Dosed Inhalers
8.1.4 Soft Mist Inhalers
8.1.5 Nebulizers
8.1.5.1 Jet Nebulizers
8.1.5.2 Ultrasonic Nebulizers
8.1.5.3 Mesh Nebulizers
8.2 United Arab Emirates Respiratory Inhalers Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Conventional Inhalers
8.2.3 Smart Inhalers
8.3 United Arab Emirates Respiratory Inhalers Market (2017-2032) by Indication
8.3.1 Market Overview
8.3.2 Asthma
8.3.3 COPD
8.4 United Arab Emirates Respiratory Inhalers Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Clinics
8.4.4 Homecare Settings
8.4.5 Others
9 Nigeria Respiratory Inhalers Market (2017-2032)
9.1 Nigeria Respiratory Inhalers Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Dry Powder Inhalers
9.1.3 Metered Dosed Inhalers
9.1.4 Soft Mist Inhalers
9.1.5 Nebulizers
9.1.5.1 Jet Nebulizers
9.1.5.2 Ultrasonic Nebulizers
9.1.5.3 Mesh Nebulizers
9.2 Nigeria Respiratory Inhalers Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Conventional Inhalers
9.2.3 Smart Inhalers
9.3 Nigeria Respiratory Inhalers Market (2017-2032) by Indication
9.3.1 Market Overview
9.3.2 Asthma
9.3.3 COPD
9.4 Nigeria Respiratory Inhalers Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Clinics
9.4.4 Homecare Settings
9.4.5 Others
10 South Africa Respiratory Inhalers Market (2017-2032)
10.1 South Africa Respiratory Inhalers Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Dry Powder Inhalers
10.1.3 Metered Dosed Inhalers
10.1.4 Soft Mist Inhalers
10.1.5 Nebulizers
10.1.5.1 Jet Nebulizers
10.1.5.2 Ultrasonic Nebulizers
10.1.5.3 Mesh Nebulizers
10.2 South Africa Respiratory Inhalers Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 Conventional Inhalers
10.2.3 Smart Inhalers
10.3 South Africa Respiratory Inhalers Market (2017-2032) by Indication
10.3.1 Market Overview
10.3.2 Asthma
10.3.3 COPD
10.4 South Africa Respiratory Inhalers Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Clinics
10.4.4 Homecare Settings
10.4.5 Others
11 Regulatory Framework
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 AstraZeneca Plc
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Beximco Pharmaceuticals Ltd.
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Boehringer Ingelheim International GmbH
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Cipla Ltd
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 GSK Plc
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Koninklijke Philips NV
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 OMRON Corp
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certification
14.9 Pari Respiratory Equipment, Inc.
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Teva Pharmaceutical Industries Ltd
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 OPKO Health, NC
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Middle East and Africa Respiratory Inhalers Market - Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security